Press Release

/DISREGARD RELEASE: M4Markets/

Up next

IASO Bio Receives Orphan Drug Designation from the Ministry of Food and Drug Safety of South Korea for Equecabtagene Autoleucel

We are advised by M4Markets that journalists and other readers should disregard the news release, M4Markets Spotlights the Big Trends: What’s Shaping the Markets in 2025, issued 08-Jul-2025 over PR Newswire.

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

SU Group Narrows First-Half Operating Loss, Executes on Long-Term Strategy

Business Momentum Led by Public-Sector Awards Across Healthcare, Cultural and Border…

Frost & Sullivan Welcomes Back Sarwant Singh to Accelerate Digital Innovation and Global Growth

Industry veteran and futurist returns to advance digital platforms, strengthen advisory…

Ontario Contributes .7 Million Investment to Advance Life Sciences Innovation at Piramal Pharma's Aurora Facility

Ontario Contributes $1.7 Million Investment to Advance Life Sciences Innovation at Piramal Pharma's Aurora Facility

Piramal Pharma Solutions is investing over $5.3 million in its Aurora drug…

Making Buildings More Energy-Efficient, Making Life Healthier

GAOBEIDIAN, China, Sept. 30, 2026 /PRNewswire/ — On September 19, the 2026…

/DISREGARD RELEASE: M4Markets/

Up next

IASO Bio Receives Orphan Drug Designation from the Ministry of Food and Drug Safety of South Korea for Equecabtagene Autoleucel

Author

CISION PRNewswire

Tags

State‑Grid Minxian Power Supply Company: Taking Multi‑pronged Measures to Safeguard Power‑supply Security

MedAdvisor Solutions' helps pharmacists in Australia deliver more than 115,000 clinical services to patients through Expanded Scope of Practice Pilots in 2024

When Eastern Intangible Heritage Meets the World Stage: Liaoning's Craftsmanship Blossoms at Expo 2025 Osaka

SU Group Narrows First-Half Operating Loss, Executes on Long-Term Strategy

Frost & Sullivan Welcomes Back Sarwant Singh to Accelerate Digital Innovation and Global Growth

Ontario Contributes $1.7 Million Investment to Advance Life Sciences Innovation at Piramal Pharma's Aurora Facility

Making Buildings More Energy-Efficient, Making Life Healthier

/DISREGARD RELEASE: M4Markets/

Up next

Author

CISION PRNewswire

Tags

You May Also Like